pargyline has been researched along with Experimental Mammary Neoplasms in 4 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Excerpt | Relevance | Reference |
---|---|---|
"Atamestane caused an increase in LH levels, while no effect was observed with oral exemestane." | 1.28 | Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours. ( di Salle, E; Giudici, D; Ornati, G; Panzeri, A; Zaccheo, T, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zimniski, SJ | 1 |
Brandt, ME | 1 |
Covey, DF | 1 |
Puett, D | 1 |
Zaccheo, T | 2 |
Giudici, D | 2 |
Ornati, G | 2 |
Panzeri, A | 1 |
di Salle, E | 2 |
Briatico, G | 1 |
Quadri, SK | 1 |
Clark, JL | 1 |
Meites, J | 1 |
4 other studies available for pargyline and Experimental Mammary Neoplasms
Article | Year |
---|---|
Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibit | 1993 |
Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; A | 1991 |
Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; A | 1989 |
Effects of LSD, pargyline and haloperidol on mammary tumor growth in rats.
Topics: Animals; Benz(a)Anthracenes; Body Weight; Female; Haloperidol; Injections, Subcutaneous; Lysergic Ac | 1973 |